יתרות מזומנים למניה אחת nyxoah.com (NYXH)

Nyxoah S.A. generates revenue from the sale of implants for people with apnea who do not use masks. The cash per share value on the precise GURU.Markets chart is recorded at 0.86, confirming the resilience of the Genio ecosystem and its proprietary software. The company is growing rapidly, planning to complete the certification of its innovative devices in the US by 2026.
פילוחים אנליטיים של חברת Nyxoah S.A (NYXH)

This indicator reflects the proportion of liquid reserves and free cash flow per share, allowing for an assessment of financial stability and the risk of capital shortages. By analyzing the amount of free cash per share, an investor can benchmark the solvency of Nyxoah S.A. (NYXH) against its competitors, evaluating the company's ability to fund the development of innovative neurostimulators for automated respiratory control without resorting to expensive debt capital.